Research, News & Discoveries

by Marissa Shapiro Oct. 21, 2020, 12:00 PM A Vanderbilt cancer systems biology team has identified the enzymes that keep tumor cells growing in the presence of drug treatment, opening the door to stopping these cells dead in their tracks. An article, “An… Read More

Oct. 20, 2020, 8:00 AM by Leigh MacMillan Interactions between microbes and host cells in the gastrointestinal tract have been implicated in the development and progression of colorectal cancer. Current techniques to study gut microbes and host cells preserve these populations separately, removing the opportunity to explore spatial interactions between… Read More

Oct. 21, 2020, 3:45 PM   by Tom Wilemon Black In Cancer, an initiative cofounded by Henry Henderson III, PhD, a postdoctoral researcher at Vanderbilt-Ingram Cancer Center, is making an impact just two months after its inception. Henry Henderson III, PhD “Black in Cancer Week,” held Oct. 11-17, focused… Read More

by Ryan Underwood Oct. 20, 2020, 11:50 AM Craig Lindsley, the William K. Warren, Jr. Chair in Medicine and University Professor of Pharmacology, Biochemistry and Chemistry, will become director of the Warren Center for Neuroscience Drug Discovery, effective Dec. 1. (John Russell/Vanderbilt)… Read More

Oct. 20, 2020, 8:45 AM by Bill Snyder Three members of the Vanderbilt University School of Medicine faculty have been elected this year to the National Academy of Medicine (NAM), the organization announced Monday, Oct. 19. They are: Nancy Carrasco, MD, professor and chair of the Department of… Read More

by Marissa Shapiro Oct. 15, 2020, 12:00 PM Vanderbilt University researchers have reported the counterintuitive discovery that certain chemotherapeutic agents used to treat tumors can have the opposite effect of tissue overgrowth in normal, intact mammary glands, epidermis and hair follicles. The researchers also… Read More

Oct. 15, 2020, 10:00 AM by Bill Snyder The novel coronavirus, SARS-CoV-2, must bind to the cell surface receptor ACE2 to enter cells and cause infection. Recently a preclinical study by an international research team found that the presence of a recombinant soluble form of human ACE2 reduced viral growth and inhibited infection. This raises… Read More

Oct. 15, 2020, 9:09 AM by Bill Snyder Researchers at Vanderbilt University Medical Center have identified a key factor that coordinates the body’s repair response to severe injury in the stomach caused, most commonly, by infection by the bacterium Helicobacter pylori. Coordinating repair is a type of white blood cell… Read More

Oct. 15, 2020, 9:00 AM by Leigh MacMillan Chronic hypoxia (low oxygen) in the brain promotes neurovascular angiogenesis — growth of new blood vessels — and remodeling, but the cell types and molecular pathways involved are not completely understood. Volker Haase, MD, and… Read More

Oct. 13, 2020, 1:44 PM by Bill Snyder AstraZeneca is advancing into phase 3 clinical trials with an investigational COVID-19 therapy of two long-acting antibodies discovered by Vanderbilt University Medical Center and optimized by AstraZeneca. On Oct. 9, AstraZeneca announced it received support from the U.S. government for the development… Read More